Food Allergy Treatment Market Report 2024

The food allergy treatment market size has grown rapidly in recent years. It will grow from $6.08 billion in 2023 to $6.82 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth during the historic period can be credited to the rise in food allergies, increased regulatory approvals, advancements in emergency treatments, and higher investments in modern technologies.

The food allergy treatment market size is expected to see rapid growth in the next few years. It will grow to $10.84 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the expanding elderly population, growing diagnoses of food allergies, increased healthcare expenditure, rising incidences of asthma, and higher prevalence of food allergies. Key trends in this period include significant innovation and technological advancements, improvements in medical technology and diagnostics, increased use of mobile apps and telemedicine services, growth in research and development activities, and a surge in drug approvals and launches.

The rise in food adulteration is expected to drive growth in the food allergy treatment market in the future. Food adulteration involves intentionally altering food products by adding inferior, harmful, or unauthorized substances or by removing valuable ingredients to increase quantity or improve appearance, often at the expense of quality and safety. This practice is increasing due to economic incentives, complex supply chains, inadequate regulation, technological advancements, demand for convenience, globalization, environmental factors, consumer awareness, profit motives, and weak enforcement of regulations. The growing prevalence of food adulteration is primarily driven by the demand for more affordable products, prompting producers to reduce costs and maximize profits through unethical means. This can elevate the risk of allergic reactions by introducing allergens into food products or compromising their safety and integrity. For example, Europol reported in November 2022 that nearly 27,000 tons of counterfeit food and 15 million liters of alcoholic beverages were seized across 26 countries between December 2021 and May 2022 as part of Operation OPSON XI. Consequently, the increasing incidence of food adulteration is fostering expansion in the food allergy treatment market.

Leading companies in the food allergy treatment sector are advancing innovative therapies, such as monoclonal antibodies, to target the underlying mechanisms of food allergies and deliver more effective treatments. Monoclonal antibodies offer a promising strategy for managing food allergies by pinpointing specific components of the immune system involved in allergic responses, thereby enhancing treatment efficacy for patients. For instance, in February 2024, Novartis AG obtained FDA approval for Xolair (omalizumab) to mitigate IgE-mediated food allergies. This humanized monoclonal antibody is administered subcutaneously and functions by blocking IgE antibody binding, thereby reducing the release of allergen-triggering chemicals. FDA clearance was supported by positive findings from the Phase III OUtMATCH study, demonstrating that a significantly higher proportion of food allergy patients, including children as young as 1 year, treated with Xolair could tolerate small amounts of peanuts, milk, eggs, and cashews without adverse reactions compared to those receiving a placebo.

In September 2023, Stallergenes Greer acquired Nestlé's peanut allergy treatment division for an undisclosed sum, enabling Nestlé to concentrate on core competencies and growth sectors while expanding Stallergenes Greer's allergy treatment offerings. Nestlé, headquartered in Switzerland, specializes in food allergy prevention and treatment.

Major companies operating in the food allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC, Novartis AG, Amgen Inc., Regeneron Pharmaceuticals Inc., Parexel International (MA) Corporation, Nestle Health Science, ALK-Abelló A/S, Stallergenes Greer, Kaleo Inc., HAL Allergy B.V., Vedanta Biosciences Inc., Aimmune Therapeutics, AnaptysBio Inc., Immunomic Therapeutics Inc., Alladapt Immunotherapeutics Inc., Aravax, Prota Therapeutics Pty Ltd., DBV Technologies, Adamis Pharmaceuticals Corporation.

North America was the largest region in the food allergy treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the food allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Treatment for food allergies involves various medical interventions aimed at preventing, managing, and treating allergic reactions triggered by specific foods. The primary objective is to decrease the frequency and severity of these reactions, improve the quality of life for affected individuals, and ensure overall patient safety.

In food allergy treatment, several types of medications play crucial roles. These include antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anti-cholinergic drugs, immuno-modulators, epinephrine, and immunotherapy. Antihistamines, for example, are medications used to relieve symptoms resulting from allergic reactions. They can be administered orally or parenterally to address various allergens such as dairy products, poultry, tree nuts, peanuts, shellfish, wheat, soy, among others. These medications are readily available from hospital pharmacies, retail pharmacies, and other distributors.

The food allergy treatment market research report is one of a series of new reports that provides food allergy treatment market statistics, including the food allergy treatment industry global market size, regional shares, competitors with food allergy treatment market share, detailed food allergy treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the food allergy treatment industry. These food allergy treatment market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The food allergy treatment market consists of revenues earned by entities by providing services such as diagnostic testing, pharmaceutical treatments, immunotherapy, nutritional supplements, emergency kits, educational programs, dietary counseling, telemedicine solutions, and research and development efforts. The market value includes the value of related goods sold by the service provider or included within the service offering. The food allergy treatment market also includes sales of medical devices, such as epinephrine auto-injectors, allergy management kits, and medical alert accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.